These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15120931)

  • 1. A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy.
    Giles FJ; Rodriguez R; Weisdorf D; Wingard JR; Martin PJ; Fleming TR; Goldberg SL; Anaissie EJ; Bolwell BJ; Chao NJ; Shea TC; Brunvand MM; Vaughan W; Petersen F; Schubert M; Lazarus HM; Maziarz RT; Silverman M; Beveridge RA; Redman R; Pulliam JG; Devitt-Risse P; Fuchs HJ; Hurd DD
    Leuk Res; 2004 Jun; 28(6):559-65. PubMed ID: 15120931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial).
    Giles FJ; Miller CB; Hurd DD; Wingard JR; Fleming TR; Sonis ST; Bradford WZ; Pulliam JG; Anaissie EJ; Beveridge RA; Brunvand MM; Martin PJ;
    Leuk Lymphoma; 2003 Jul; 44(7):1165-72. PubMed ID: 12916869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: analysis from a multicenter, double-blind, placebo-controlled, randomized, phase III clinical trial.
    Elad S; Epstein JB; Raber-Durlacher J; Donnelly P; Strahilevitz J
    J Oral Pathol Med; 2012 Mar; 41(3):229-34. PubMed ID: 22077420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.
    Trotti A; Garden A; Warde P; Symonds P; Langer C; Redman R; Pajak TF; Fleming TR; Henke M; Bourhis J; Rosenthal DI; Junor E; Cmelak A; Sheehan F; Pulliam J; Devitt-Risse P; Fuchs H; Chambers M; O'Sullivan B; Ang KK
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):674-81. PubMed ID: 14967419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy.
    Limaye SA; Haddad RI; Cilli F; Sonis ST; Colevas AD; Brennan MT; Hu KS; Murphy BA
    Cancer; 2013 Dec; 119(24):4268-76. PubMed ID: 24114811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of pain associated with oral mucositis during the acute period after administration of high-dose chemotherapy.
    Cella D; Pulliam J; Fuchs H; Miller C; Hurd D; Wingard JR; Sonis ST; Martin PJ; Giles F
    Cancer; 2003 Jul; 98(2):406-12. PubMed ID: 12872363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iseganan HCl: a novel antimicrobial agent.
    Giles FJ; Redman R; Yazji S; Bellm L
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1161-70. PubMed ID: 12150709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study.
    Dazzi C; Cariello A; Giovanis P; Monti M; Vertogen B; Leoni M; Tienghi A; Turci D; Rosti G; Nanni O; Rondoni C; Marangolo M
    Ann Oncol; 2003 Apr; 14(4):559-63. PubMed ID: 12649101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iseganan (IntraBiotics pharmaceuticals).
    Toney JH
    Curr Opin Investig Drugs; 2002 Feb; 3(2):225-8. PubMed ID: 12020050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse.
    Weisdorf DJ; Bostrom B; Raether D; Mattingly M; Walker P; Pihlstrom B; Ferrieri P; Haake R; Goldman A; Woods W
    Bone Marrow Transplant; 1989 Jan; 4(1):89-95. PubMed ID: 2647192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, placebo-controlled, randomized trial to evaluate the role of tetrachlorodecaoxide in the management of chemotherapy-induced oral mucositis.
    Malik IA; Moid I; Haq S; Sabih M
    J Pain Symptom Manage; 1997 Aug; 14(2):82-7. PubMed ID: 9262037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment.
    Lozano A; Marruecos J; Rubió J; Farré N; Gómez-Millán J; Morera R; Planas I; Lanzuela M; Vázquez-Masedo MG; Cascallar L; Giralt J; Escames G; Valentí V; Grima P; Bosser R; Tarragó C; Mesía R
    Clin Transl Oncol; 2021 Sep; 23(9):1801-1810. PubMed ID: 33738704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palifermin for oral mucositis after intensive therapy for hematologic cancers.
    Spielberger R; Stiff P; Bensinger W; Gentile T; Weisdorf D; Kewalramani T; Shea T; Yanovich S; Hansen K; Noga S; McCarty J; LeMaistre CF; Sung EC; Blazar BR; Elhardt D; Chen MG; Emmanouilides C
    N Engl J Med; 2004 Dec; 351(25):2590-8. PubMed ID: 15602019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chlorhexidine during immunosuppressive chemotherapy. A preliminary report.
    Rutkauskas JS; Davis JW
    Oral Surg Oral Med Oral Pathol; 1993 Oct; 76(4):441-8. PubMed ID: 8233423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.
    Stiff PJ; Emmanouilides C; Bensinger WI; Gentile T; Blazar B; Shea TC; Lu J; Isitt J; Cesano A; Spielberger R
    J Clin Oncol; 2006 Nov; 24(33):5186-93. PubMed ID: 16391299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation.
    Freytes CO; Ratanatharathorn V; Taylor C; Abboud C; Chesser N; Restrepo A; Arango J; Odenheimer D
    Clin Cancer Res; 2004 Dec; 10(24):8318-24. PubMed ID: 15623608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy.
    Lalla RV; Gordon GB; Schubert M; Silverman S; Hutten M; Sonis ST; LeVeque F; Peterson DE
    Support Care Cancer; 2012 Aug; 20(8):1797-804. PubMed ID: 21964618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.
    Vadhan-Raj S; Trent J; Patel S; Zhou X; Johnson MM; Araujo D; Ludwig JA; O'Roark S; Gillenwater AM; Bueso-Ramos C; El-Naggar AK; Benjamin RS
    Ann Intern Med; 2010 Sep; 153(6):358-67. PubMed ID: 20855800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study.
    Aquino VM; Harvey AR; Garvin JH; Godder KT; Nieder ML; Adams RH; Jackson GB; Sandler ES
    Bone Marrow Transplant; 2005 Oct; 36(7):611-6. PubMed ID: 16086046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for preventing oral mucositis for patients with cancer receiving treatment.
    Worthington HV; Clarkson JE; Eden OB
    Cochrane Database Syst Rev; 2006 Apr; (2):CD000978. PubMed ID: 16625538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.